Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Malin Forsgard"'
Autor:
Martijn J. Wilmer, Ernst Ahlberg, Mikael Persson, Simone H. Stahl, Anna-Karin Sjögren, Malin Forsgard, Jorrit J. Hornberg, Lucas Milton, Katarina Breitholtz
Publikováno v:
Archives of Toxicology, 92, 3175-3190
Archives of Toxicology, 92, 10, pp. 3175-3190
Archives of Toxicology, 92, 10, pp. 3175-3190
Contains fulltext : 196765.pdf (Publisher’s version ) (Closed access) Drug-induced nephrotoxicity is a major concern in the clinic and hampers the use of available treatments as well as the development of innovative medicines. It is typically disco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86edfea0e525dda11ec47e606d0d0513
https://doi.org/10.1007/s00204-018-2284-y
https://doi.org/10.1007/s00204-018-2284-y
Publikováno v:
C58. MECHANISMS OF PULMONARY FIBROSIS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6453af62fc80ca39d181e55c797a1900
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5248
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5248
Autor:
Olga Shatnyeva, Emilyanne Leonard, Xabier Osteikoetxea, Mick D. Fellows, Amer F. Saleh, Nicholas Edmunds, Madeleine Ingelsten, Elisa Lázaro-Ibáñez, Maryam Clausen, Stephanie M. Bates, Niek Dekker, Fredrik Karlsson, Damla Etal, Nikki Heath, Jonathan A. Rose, Jayne Harris, Maelle Mairesse, Malin Forsgard
Publikováno v:
Nanoscale. 11(14)
Extracellular vesicles (EVs) mediate cellular communication through the transfer of active biomolecules, raising interest in using them as biological delivery vehicles for therapeutic drugs. For drug delivery applications, it is important to understa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b56b3955673a81597a009549e206474c
https://pubmed.ncbi.nlm.nih.gov/30916672
https://pubmed.ncbi.nlm.nih.gov/30916672
Autor:
Anna-Karin Sjögren, Jorrit J. Hornberg, Malin Forsgard, Katarina Breitholtz, Martijn J. Wilmer, Mikael Persson, Lucas Milton, Simone H. Stahl, Katherine S. Fenner
Publikováno v:
Toxicology Letters. 280:S138
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf015a1bd2931135844c76f77f10a49e
https://doi.org/10.1016/j.toxlet.2017.07.386
https://doi.org/10.1016/j.toxlet.2017.07.386
Autor:
Ganesh Rajaraman, Xiaoyan Chu, Ailan Guo, Sibylle Neuhoff, Imad Hanna, Caroline A. Lee, Heleen M. Wortelboer, Guangqing Xiao, Malin Forsgard, Tetsuo Yamagata, Masoud Jamei, Sophie P Chung, Laurent Salphati, Isabelle Ragueneau-Majlessi, Johan E. Palm, Joann Coleman, Michael P. O'Connor, Praveen Balimane, Anne Y. Pak, Libin Li, Kathleen M. Hillgren, Lei Zhang, Krisztina Herédi-Szabó, Jan Shiang Taur, Joe Bentz, Mitchell E. Taub, Shibing Deng, Elke S Perloff, Dietmar Weitz, Harma Ellens, Cindy Q. Xia, Christoph Funk, Dallas Bednarczyk
Publikováno v:
Drug Metabolism and Disposition, 7, 41, 1367-1374
In the 2012 Food and Drug Administration (FDA) draft guidance on drug-drug interactions (DDIs), a new molecular entity that inhibits Pglycoprotein (P-gp) may need a clinical DDI study with a P-gp substrate such as digoxin when themaximumconcentration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba6f60f0f2a333fa7a0b3ee295536585
https://europepmc.org/articles/PMC3684818/
https://europepmc.org/articles/PMC3684818/
